Shandong Lukang Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shandong Lukang Pharmaceutical Co., Ltd. (referred to as Lukang Pharmaceutical) is a state-owned comprehensive pharmaceutical enterprise, established in 1966 and listed on the main board of the Shanghai Stock Exchange in 1997 (stock code: 600789). In 2006, Lukang Pharmaceutical belonged to Hualu Holding Group Co., Ltd. Hualu Group was the first wholly-owned company established overseas in Shandong Province and a window company for economic and trade activities in the Hong Kong region in Shandong Province. The company focuses on the three main businesses of high-end chemicals, biopharmaceuticals, and ecological environmental protection, and actually controls three listed companies, including Hualu Hengsheng, Xinhua Pharmaceutical, and Lukang Pharmaceutical, as well as four stocks, as well as five non listed companies, including the Provincial Academy of Environmental Sciences and Hong Kong Hualu, with 55 owned enterprises. Lukang Pharmaceutical is a vice president unit of the China Chemical Pharmaceutical Industry Association, China Pharmaceutical Enterprise Management Association, and Shandong Pharmaceutical Management Association. Lukang Pharmaceutical is a top 100 enterprise in China's pharmaceutical industry, a national high-tech enterprise, a pilot enterprise for the integration of industrialization and information technology by the Ministry of Industry and Information Technology, a key export brand cultivated and developed by the Ministry of Commerce, and a national "green factory" recognized by the Ministry of Ecology and Environmental Protection; It is one of the first batch of "National Comprehensive New Drug R&D Technology Platform (Shandong) Industrialization Demonstration Enterprises" and "Key High tech Enterprises of the National Torch Plan"; It is a national advanced enterprise with quality and efficiency, a demonstration enterprise for drug quality and integrity construction, a benchmark enterprise for the 40 years of reform and opening up, and the most valuable brand enterprise for Chinese medicine; It is a leading enterprise in the "Top Ten" industrial cluster of Shandong Province and a high-end brand cultivation enterprise in the manufacturing industry of Shandong Province. Lukang Pharmaceutical's main business covers major industrial sectors such as human raw materials, human pharmaceutical preparations, animal and plant health drugs, and environmental protection technology. Having over 200 product codes and over 500 variety specifications; There are 67 product specifications ranking among the top ten in the country, and 18 product specifications ranking first in the country. The company has passed national GMP certification, ISO9000 series, ISO14001, occupational health and safety management system certification, as well as international high-end certifications such as FDA in the United States and CEP in Europe. Its products are exported to more than 40 countries and regions. Lukang Pharmaceutical has 5 national high-tech enterprises, 1 national enterprise technology center, 3 Shandong Province enterprise technology centers, 1 provincial engineering technology research center, and 1 green pharmaceutical engineering laboratory each. We have established major research and development platforms such as the Shandong Provincial Industrial Biotechnology Industry Transformation Platform, Shandong Provincial Brand International Science and Technology Cooperation Base, Shandong University Shandong Anti Microbial Technology Research Institute, Middle Paleontology Biotechnology International Cooperation Center, Academician Workstation, and Postdoctoral Research Workstation. Since 2015, Lukang Pharmaceutical has invested over 4 billion yuan to implement the strategy of retreating from the city and entering the park. Two major parks, namely the Biopharmaceutical Circular Economy Industrial Park and the High tech Biotechnology Industrial Park, have been established, forming two biopharmaceutical industry clusters in Jining High tech Zone and Zoucheng City. The new park is built according to six standards: environmental protection priority, concentrated production capacity, economic intensification, technology integration, international standards, and intelligent manufacturing. Lukang Pharmaceutical has become a model for the relocation of enterprises of the same scale in the industry. Returning to the city and entering the park has promoted the transformation of Lukang's old and new driving forces, laying the foundation for the enterprise to achieve high-quality development. New era, new resistance, new dreams, new future. Keeping humans away from the pain of diseases is the mission and unremitting pursuit of Lukang. Guided by the core values of "innovation, quality, and conduct", during the "14th Five Year Plan" period, Lukang Pharmaceutical adheres to the new development concept and the "dual core development" strategy, strives to make breakthroughs in innovative drug research and development, biotechnology applications, intelligent manufacturing, and excellent performance management, constructs a new development pattern, and builds a respected century old enterprise, Make greater contributions to the cause of Chinese medicine and human health!. |
| Headquarter | Jining |
| Establish Date | 2/15/1993 |
| Listed Code | 600789.SH |
| Listed Date | 2/26/1997 |
| Chairman | Peng Xin. |
| CEO | Dong Kun. |
| Website | www.lkpc.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
